by Mike Montana
WE CAN’T MAKE CHANGES FOR A BETTER FUTURE (OR PRESENT) IF WE’RE ONLY WORRIED ABOUT – AND REACTING TO – WHAT HAPPENED IN THE PAST, SAYS COLD CHAIN EXPERT AND PRESIDENT OF MODALITY SOLUTIONS, GARY HUTCHINSON.
The pharmaceutical industry has learned a lot of lessons since early 2020, but it doesn’t seem like those lessons are leading to changes – at least not fast enough – says Gary Hutchinson, President, Modality Solutions.
My colleague Ashley Barey and I recently sat down with Gary to discuss why it is taking so long for the pharma industry to change its supply chain model despite overwhelming proof the current model isn’t working. He did not hold back in pointing out some current process and technology deficiencies, nor did he refrain from offering what I feel are very practical recommendations on what the pharma industry (and all cold chain industries) should be doing differently going forward.
So, if you’re interested in learning about the good, bad and the ugly of today’s cold chain monitoring and quality control for temperature-sensitive drugs or you want to find out the “good, better and best” approaches to pharma supply chain management moving forward, read the excerpts from our discussion below. I included an audio clip from part of our conversation, as I felt it was important for you to actually hear what Gary has to say about the risks versus benefits of change. What he shared will either lead you to shake your head in amazement or nod in agreement (or maybe a little of both). Read more >
